SCHEMBL15449488

CC(=O)N[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3[C@H](OS(=O)(=O)O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@H]4[C@H](O)[C@@H](OS(=O)(=O)O)[C@H](O[C@H]5[C@H](O)[C@@H](NS(=O)(=O)O)[C@@H](C)O[C@@H]5COS(=O)(=O)O)O[C@H]4C(=O)O)O[C@@H]3COS(=O)(=O)O)O[C@@H]2C(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2OC(C(=O)O)=C[C@H](O)[C@H]2O)[C@@H]1O

nearest known ligand 0.63

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	F10	P00742	3/20	0.63

▸	BDNF	P23560	3/20	0.47

▸	MDK	P21741	3/20	0.47

▸	PTN	P21246	2/20	0.47

▸	BMP2	P12643	2/20	0.43

▸	VEGFA	P15692	2/20	0.43

▸	CXCL12	P48061	2/20	0.43

▸	SHH	Q15465	2/20	0.43

▸	IFNG	P01579	1/20	0.43

▸	PF4	P02776	1/20	0.43

▸	CCL2	P13500	1/20	0.43

▸	SELP	P16109	1/20	0.43

▸	BMP6	P22004	1/20	0.43

▸	CCL11	P51671	1/20	0.43

▸	WNT3A	P56704	1/20	0.43

▸	SELPLG	Q14242	1/20	0.43

▸	F9	P00740	3/20	0.42

▸	F8	P00451	2/20	0.42

▸	HPSE	Q9Y251	4/20	0.40

▸	FGF2	P09038	2/20	0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL12532640	1.00	F10 (0.63)	F10BDNFMDKPTNBMP2
SCHEMBL12532633	0.94	F10 (0.64)	F10BDNFMDKPTNBMP2
SCHEMBL15452227	0.94	F10 (0.73)	F10BDNFMDKPTNBMP2
SCHEMBL15452229	0.94	F10 (0.71)	F10BDNFMDKPTNBMP2
SCHEMBL15452279	0.94	F10 (0.73)	F10BDNFMDKPTNBMP2
SCHEMBL15452230	0.94	F10 (0.73)	F10BDNFMDKPTNBMP2
SCHEMBL17771210	0.94	F10 (0.73)	F10BDNFMDKPTNBMP2
SCHEMBL15449547	0.94	F10 (0.71)	F10BDNFMDKPTNBMP2
SCHEMBL15452259	0.94	F10 (0.73)	F10BDNFMDKPTNBMP2
SCHEMBL17771213	0.94	F10 (0.73)	F10BDNFMDKPTNBMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-9346894-B2	Polysaccharides comprising two antithrombin III-binding sites, preparation thereof and use thereof as antithrombotic medicaments	SANOFI (FR)	2016-05-24	—	—	US	disclosed
US-9346894-B2	Polysaccharides comprising two antithrombin III-binding sites, preparation thereof and use thereof as antithrombotic medicaments	SANOFI (FR)	2016-05-24	—	—	US	disclosed
US-20140031316-A1	POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS	SANOFI (FR)	2014-01-30	—	—	US	disclosed
US-20140031316-A1	POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS	SANOFI (FR)	2014-01-30	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20140031316-A1	POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS	SERPINC1, F13B, F12	F10 16/4885BDNF 2320/4885MDK 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.